Journal
ANALYTICAL CHEMISTRY
Volume 93, Issue 11, Pages 4984-4992Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.1c00374
Keywords
-
Categories
Funding
- Natural Science Foundation of China [NSFC 81801744]
- National Key R&D Program of China [2017YFA0205202, 2017YFC1309100]
Ask authors/readers for more resources
The study proposes a strategy of combining antibodies with optical probes for the precise diagnosis of lung adenocarcinoma, utilizing hub genes and designed fluorescence imaging probes with multimodal optical imaging properties. The results show that this dual-modal luminescence imaging method can be excellently used for accurate diagnosis and surgery navigation.
In this research, the antibody of the searched hub genes has been proposed to combine with a rare-earth composite for an upconversion luminescence (UCL) and downconversion (DCL) NIR-II imaging strategy for the diagnosis of lung adenocarcinoma (LUAD). Weighted gene co-expression network analysis is used to search the most relevant hub genes, and the required top genes that contribute to tumorigenesis (negative: CLEC3B, MFAP4, PECAM1, and FHL1; positive: CCNB2, CDCA5, HMMR, and TOP2A) are identified and validated by survival analysis and transcriptional and translational results. Meanwhile, fluorescence imaging probes (NaYF4:Yb,Er,Eu@ NaYF4:Nd, denoted as NYF:Eu NPs) with multimodal optical imaging properties of downconversion and upconversion luminescence in the visible region and luminescence in the near infrared II region are designed with various uniform sizes and enhanced penetration and sensitivity. Finally, when the NYF:Eu NP probe is combined with antibodies of these chosen positive hub genes (such as, TOP2A and CCNB2), the in vitro and in vivo animal experiments (flow cytometry, cell counting kit-8 assay using A549 cells, and in vivo immunohistochemistry IHC microscopy images of LUAD from patient cases) indicate that the designed nanoprobes can be excellently used as a targeted optical probe for future accurate diagnosis and surgery navigation of LUAD in contrast with other cancer cells and normal cells. This strategy of antibodies combined with optical probes provides a dual-modal luminescence imaging method for precise medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available